# Revolution Medicines, Inc. (RVMD) FY2024 Q3 P&L / Income Statement

- Company: Revolution Medicines, Inc. (RVMD)
- Period: 2024-07-01 to 2024-09-30
- Filing: Q3 FY2024 10-Q, filed 2024-11-06, accession number 0000950170-24-122303
- Page: https://plicit.ai/financials/rvmd/fy2024-q3-income-statement
- Chart image: https://plicit.ai/charts/rvmd-fy2024-q3-income-statement-sankey.png

## Chart details

Income statement for 2024-07-01 through 2024-09-30. Consolidated revenue, costs and expenses.

- **Total revenue**: 0 US dollars
- **Total operating expenses**: 175,712,000 US dollars
- **Loss from operations**: negative 175,712,000 US dollars
- **Total other income, net**: 19,424,000 US dollars
- **Loss before income taxes**: negative 156,288,000 US dollars
- **Benefit from income taxes**: 0 US dollars
- **Net loss**: negative 156,288,000 US dollars
- **Total operating expenses**: 175,712,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.